Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorKaili Chen

About this trial

This randomized controlled study in patients with post-stroke dysphagia aims to determine the optimal stimulation frequency of electroacupuncture of the suprahyoid muscles and to elucidate the underlying neural mechanisms. Participants will be assigned to low-frequency (2 Hz), medium-frequency (50 Hz), or high-frequency (100 Hz) electroacupuncture groups. Therapeutic efficacy will be assessed using the Kubota water-drinking test, videofluoroscopic swallowing study (VFSS), and ultrasonography to identify the optimal frequency. In parallel, diffusion tensor imaging (DTI) will be used to evaluate changes in fiber connectivity between swallowing-related cortical regions (bilateral precentral gyrus, insula, supramarginal gyrus, and frontal lobe) and the medullary nucleus tractus solitarius, thereby exploring neural network remodeling and providing mechanistic evidence to inform clinical practice.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis: Patients diagnosed with cerebral infarction confirmed by CT or MRI.

Dysphagia Screening: Presence of varying degrees of dysphagia as screened by the Water Swallow Test (WST).

Clinical Status: Conscious and stable vital signs, with the ability to cooperate with the treatment.

Age: Aged between 18 and 80 years.

Disqualifiers

Dysphagia Etiology: Patients with dysphagia caused by etiologies other than cerebral infarction.

MRI Contraindications: Patients with metal implants or pacemakers in the body (contraindications for MRI).

Bleeding Risk: Patients with bleeding tendencies or coagulation disorders.

Blood Pressure: Patients with uncontrolled hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 120 mmHg).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Low Frequency EA

    Device

    Electroacupuncture will be applied to the suprahyoid muscles. The stimulation frequency will be set at 2 Hz (Low Frequency). The intensity should be adjusted to the patient's tolerance, utilizing a discontinuous waveform. Treatment is administered once daily for 30 minutes, with a course cosisting of 7 sessions. A rest day is observed between courses, and the treatment is continued for a total of 6 courses.

  • Medium Frequency EA

    Device

    Electroacupuncture will be applied to the suprahyoid muscles. The stimulation frequency will be set at 50 Hz (Medium Frequency). The intensity should be adjusted to the patient's tolerance, utilizing a discontinuous waveform. Treatment is administered once daily for 30 minutes, with a course cosisting of 7 sessions. A rest day is observed between courses, and the treatment is continued for a total of 6 courses.

  • High Frequency EA

    Device

    Electroacupuncture will be applied to the suprahyoid muscles. The stimulation frequency will be set at 100 Hz (High Frequency).The intensity should be adjusted to the patient's tolerance, utilizing a discontinuous waveform. Treatment is administered once daily for 30 minutes, with a course cosisting of 7 sessions. A rest day is observed between courses, and the treatment is continued for a total of 6 courses.

Treatment groups

102 Participants
are divided into 3 treatment groups
Group A: Low Frequency EAExperimental treatment 1 intervention
Group B: Medium Frequency EAExperimental treatment 1 intervention
Group C: High Frequency EAExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Water Swallow Test (WST) Score

The WST is a screening tool for dysphagia. It assesses the ability to swallow water and the presence of coughing or choking. Scores range from 1 to 5, with higher scores indicating more severe dysphagia. Improvement is defined as a decrease in the WST score.

Time frame
Baseline and Week 6 (End of treatment)

Secondary outcomes

1

Change in Penetration-Aspiration Scale (PAS) Score via VFSS

The PAS is an 8-point scale used to describe the severity of penetration and aspiration events during a Videofluoroscopic Swallowing Study (VFSS). Lower scores indicate safer swallowing function.

Time frame
Baseline and Week 6 (End of treatment)
2

Hyolaryngeal excursion measured by Ultrasound

B-mode ultrasound will be used to measure the anterior and superior displacement distance of the hyoid bone and larynx during swallowing. Greater displacement indicates better function of the suprahyoid muscles.

Time frame
Baseline and Week 6 (End of treatment)
3

Changes in Fractional Anisotropy (FA) values of swallowing-related neural pathways

Diffusion Tensor Imaging (DTI) will be used to measure the Fractional Anisotropy (FA) values of white matter fiber tracts connecting the bilateral precentral gyrus, insula, supramarginal gyrus, frontal lobe, and the nucleus of the solitary tract. Higher FA values indicate better structural integrity of the neural network.

Time frame
Baseline and Week 6 (End of treatment)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kaili Chen

Lead sponsor

The Third Affiliated hospital of Zhejiang Chinese Medical University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: